| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Pre-mRNA-processing factor 17;Cell division cycle 40 homolog;EH-binding protein 3;Ehb3;PRP17 homolog;hPRP17;CDC40;EHB3, PRP17, PRPF17; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | A synthesized peptide derived from human DPP3 |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-DPP3 Rabbit Monoclonal Antibody catalog # M07788-1. Tested in WB, Flow Cytometry applications. This antibody reacts with Human.
Protein: T-cell surface glycoprotein CD3 zeta chain | Gene: Pre-mRNA-processing factor 17 | Target: DPP3 | Function: Associates with the spliceosome late in the splicing pathway and may function in the second step of pre-mRNA splicing. . | Research areas: Cancer,Cell Biology,Cell Cycle,Cell Division,DNA/RNA,Epigenetics and Nuclear Signaling,RNA Processing,Splicing
Host: Rabbit | Clonality/Clone: Monoclonal / Clone: 27D57 | Isotype: IgG | Reactivity: Human | Immunogen: A synthesized peptide derived from human DPP3 | Concentration: 0.5mg/ml | Purification: Affinity-chromatography
Applications: WB, ICC, FC
Observed MW: 83 kDa | Calculated MW: 65521 MW
Cellular localization: Nucleus .
Tissue details: Brain.
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
